Results 211 to 220 of about 68,419 (263)

Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial. [PDF]

EBioMedicine
Pagnon A, Carre C, Aguirre M, Chautard E, Gimenez S, Raynal F, Feroldi E, Scott P, Modjarrad K, Vangelisti M, Mantel N.   +10 more
europepmc   +1 more source

A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old [PDF]

, 2015
Collaborative Group for Studies of Yellow Fever Vaccine
openalex   +1 more source

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan. [PDF]

Trials
Mackenzie GA, Osei I, Salaudeen R, Licciardi PV, Greenwood B, Mulholland K, Nguyen C.   +6 more
europepmc   +1 more source

Yellow Fever Vaccine-Associated Neurotropic Disease: A Case Report Of A 9-Month Old Infant And Review Of Literature

Chimaeze Torty, Chimereze Anthony Amajor, Olusola Bolaji Adewale   +2 more
openalex   +2 more sources

Yellow Fever Vaccination [PDF]

American Journal of Public Health and the Nations Health, 1956
openaire   +1 more source

Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics. [PDF]

Braz J Infect Dis
Motta E, Camacho LAB, Filippis AMB, Costa M, Pedro L, Cardoso SW, Souza MCO, Mendes YDS, Grinsztejn B, Coelho LE.   +9 more
europepmc   +1 more source

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report. [PDF]

Vaccine
Casey RM, Najjengo MS, Lubega I, Sekiziyivu AB, Twinomuhwezi-Oyet E, Nakato WN, Sciarratta CN, Chu SY, Doshi RH, Kambugu A, Gidudu JF.   +10 more
europepmc   +1 more source

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.

Vaccine, 2021
Piras-Douce F, Raynal F, Raquin A, Girerd-Chambaz Y, Gautheron S, Sanchez MEN, Vangelisti M, Mantel N.   +7 more
europepmc   +1 more source

Impact of yellow fever vaccine on patients with psoriasis: preliminary results. [PDF]

An Bras Dermatol, 2019
de Barros MH, Avelleira JCR, Mendes KAP.
europepmc   +1 more source